A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…
The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, an expanding patient population, and rising adoption of premium-priced drug-…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific IC market in 2020, the market has shown strong recovery and will resume prepandemic growth trends in the near term. Going…
The European EP mapping and ablation device market will experience moderate growth through 2032 due to increasing ablation procedure volumes, technological advancements, and the uptake of premium-…
The Asia Pacific neurovascular device market will see strong growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing…
The European vascular access device market is well-established and will grow marginally over the forecast period. Unit sales will be supported by steady growth in the underlying patient population…
The European neurovascular device market will see strong growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data as well as access to the…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to…
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth…
The US PV device market will be driven by the continued rise in adoption of various endovascular treatment techniques and innovative product launches supported by favorable reimbursement programs,…
The Japanese TEO device market will see modest growth over the forecast period driven by growing adoption of minimally invasive treatment options like embolization, increasing product launches, and…
The US cardiac assist device market will continue to experience growth after recovering from the impact of the COVID-19 pandemic. The market will be driven by expanded use of cardiac assist devices…
The US vascular access device market will grow slowly over the forecast period. On one hand, unit sales will be supported by steady growth in the underlying patient population undergoing medical…
A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…